The The Chemours Company (NYSE:CC) is going down by -3.97% in today’s trading session, a fall equivalent to -0.5% of the stock’s price from yesterday’s market close. A news came out 19 hours ago stating that Copy insiders and buy these stocks — because they see no recession looming by MARKETWATCH. The lowest point that the shares touched during the trading session was $12.33, while the peak of the day was recorded at a share price of $13.14. CC finished the previous session at $12.60 according to the data provided by Barchart, while the trading volume was observed to be $1,594,496.
In the 100 days of trading, CC managed to top a 26.13% Moving average. Additionally, The Chemours Company shares have achieved a 52-week range between 12.33 and 46.13 alongside 100 days raw stochastic set at 1.01%.
The number of shares outstanding, according to the fundamentals of the company, is set at 177.68M, equal to the value of $2.24B in market capitalization. Financial analysts indicate that CC shares should be still ranked as a “Outperform”. In the last 30 days, The Chemours Company shares went down by -41.63%, adding 20.73 to growth in value, on top of a +2.54% boost since 07/12/19.
The Chemours Company (NYSE:CC) Analyst’s Estimates
The Chemours Company (CC) could record at least $0.67 per share in quarterly earnings in the upcoming report on 10/30/2019, a number that would actually represent an increase of 58.25% YOY.
According to the average analyst rating, The Chemours Company would be rated as 2.29. Out of 14 different analysts monitoring CC stock, 2 analysts rate the stock as a BUY, 6 suggest to give the rating of HOLD, 6 indicate that CC is an OUTPERFORM, 0 rated the stock as a SELL, and 0 analyst believes that the stock should be rated as UNDERPERFORM.
On Aug-09-19, the stock earned a Downgrade rating due to a new analyst call from RBC Capital Mkts, while analysts from Argus believe that the stock is set at Hold from Buy, as concluded on Aug-06-19. SunTrust, is still rather wary about the stock, deciding to keep the rating at Hold as confirmed through a call on Aug-05-19.
Regardless of the rating, Citigroup did decrease their price from $40 to $20 as they are considering target share price analysis. JP Morgan, on the other hand, provided a rather enthusiastic opinion on the rating, concluded in an analyst call on May-06-19, giving the stock a Neutral from the Overweight rating.
CC Key Ratios To Watch:
Taking in account the profitability of the Company, gross profit margin of +30.17% has been attained, while the operating margin has been recorded at +18.50%. The firm is also showcasing profitability through returns on assets in the company’s ownership, with ROA set at 13.58%. Beta value of the stock is recorded at 2.47. Additionally, The Chemours Company is recording price volatility of 6.55% for the period of the last seven days and 5.95% in the last 30 days.
The Chemours Company (NYSE:CC) Technical Outlook
For the period of the last 50 days, The Chemours Company had its Raw Stochastic average set at 2.21% for the latest technical analysis. In comparison to the period of the last 20 days, the present Raw Stochastic average for the last 50 days poses as improvement, set at 3.55%. Stochastic %K for The Chemours Company, with the last 20 days included, was set at 2.56%, having Stochastic %D topping 3.53%. Based on the previous performance of the company for the mentioned period, there are more than several recorded moving trends. When it comes to the period of the last 12 months, accounting the time for year-to-date, price performance appears to be discouraging for The Chemours Company stocks with recording -72.01% in metrics.
The Chemours Company Insider Watch:
As far as the position of shares issued by The Chemours Company (NYSE:CC) for the period concluded at the market close of 08/13/19, 177 institutional investors increased their positions in CC shares by 14,228,667, 287 decreased positions by 25,231,053 and 117 institutional investors decided to hold positions at 85,211,374. These numbers put the complete list of institutional holdings set at 124,671,094 shares, in accordance with filings submitted to the Securities and Exchange Commission. The stock had another 58 institutional investments with 3,851,896 new shares in addition to having 93 institutional investors selling their positions in 13,029,759 shares.